ICRF has awarded more than $93 million in funding to support over 2,800 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s) Institution Grant Type Research Topics Grant Status
David Meiri, PhD Technion, Israel Institute of Technology Project Grant Blood Cancers, Cannabinoids Active
Yifat Merbl, PhD Weizmann Institute of Science ICRF-Cancer Research Institute Clinic and Laboratory Integration Program Grant Immunology and Immunotherapy, Melanoma Active
Eran Meshorer, PhD Hebrew University of Jerusalem Project Grant Brain Cancer Active
Lirin Michaeli, PhD Tel Aviv University Postdoctoral Fellowship Cancer Treatment, Experimental Therapeutics, Proteomics and Protein Structures Non-active
Neta Milman, PhD Rambam Health Care Campus Barbara S. Goodman Endowed Research Career Development Award for Pancreatic Cancer Immunology and Immunotherapy, Pancreatic Cancer Non-active
Michael Milyavsky, PhD Tel Aviv University Project Grant Genetics and Genomics, Leukemia, Pediatric Cancer Non-active
Ariel Munitz, PhD Tel Aviv University ICRF-City of Hope Jacki and Bruce Barron Cancer Research Scholars’ Program Grant Cancer Metastasis, Immunology and Immunotherapy Non-active
Ariel Munitz, PhD Tel Aviv University Project Grant Cancer Metastasis, Immunology and Immunotherapy, Lung Cancer, Microenvironment Active
Lior Nissim, PhD Hebrew University of Jerusalem ICRF-Cancer Research Institute Immunotherapy Promise Grant Clinical and Translational Research, Immunology and Immunotherapy, Lung Cancer, Synthetic Gene Circuits Non-active
Yarden Opatowsky, PhD Bar-Ilan University Project Grant Chemotherapy, Quality of Life Active